Cargando…

High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa

Retinitis pigmentosa is the most frequent group of inherited retinal dystrophies. It is highly heterogeneous, with more than 80 disease-causing genes 27 of which are known to cause autosomal dominant RP (adRP), having been identified. In this study a total of 29 index cases were ascertained based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezquerra-Inchausti, Maitane, Barandika, Olatz, Anasagasti, Ander, Irigoyen, Cristina, López de Munain, Adolfo, Ruiz-Ederra, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206707/
https://www.ncbi.nlm.nih.gov/pubmed/28045043
http://dx.doi.org/10.1038/srep39652
_version_ 1782490287158853632
author Ezquerra-Inchausti, Maitane
Barandika, Olatz
Anasagasti, Ander
Irigoyen, Cristina
López de Munain, Adolfo
Ruiz-Ederra, Javier
author_facet Ezquerra-Inchausti, Maitane
Barandika, Olatz
Anasagasti, Ander
Irigoyen, Cristina
López de Munain, Adolfo
Ruiz-Ederra, Javier
author_sort Ezquerra-Inchausti, Maitane
collection PubMed
description Retinitis pigmentosa is the most frequent group of inherited retinal dystrophies. It is highly heterogeneous, with more than 80 disease-causing genes 27 of which are known to cause autosomal dominant RP (adRP), having been identified. In this study a total of 29 index cases were ascertained based on a family tree compatible with adRP. A custom panel of 31 adRP genes was analysed by targeted next-generation sequencing using the Ion PGM platform in combination with Sanger sequencing. This allowed us to detect putative disease-causing mutations in 14 out of the 29 (48.28%) families analysed. Remarkably, around 38% of all adRP cases analysed showed mutations affecting the splicing process, mainly due to mutations in genes coding for spliceosome factors (SNRNP200 and PRPF8) but also due to splice-site mutations in RHO. Twelve of the 14 mutations found had been reported previously and two were novel mutations found in PRPF8 in two unrelated patients. In conclusion, our results will lead to more accurate genetic counselling and will contribute to a better characterisation of the disease. In addition, they may have a therapeutic impact in the future given the large number of studies currently underway based on targeted RNA splicing for therapeutic purposes.
format Online
Article
Text
id pubmed-5206707
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-52067072017-01-04 High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa Ezquerra-Inchausti, Maitane Barandika, Olatz Anasagasti, Ander Irigoyen, Cristina López de Munain, Adolfo Ruiz-Ederra, Javier Sci Rep Article Retinitis pigmentosa is the most frequent group of inherited retinal dystrophies. It is highly heterogeneous, with more than 80 disease-causing genes 27 of which are known to cause autosomal dominant RP (adRP), having been identified. In this study a total of 29 index cases were ascertained based on a family tree compatible with adRP. A custom panel of 31 adRP genes was analysed by targeted next-generation sequencing using the Ion PGM platform in combination with Sanger sequencing. This allowed us to detect putative disease-causing mutations in 14 out of the 29 (48.28%) families analysed. Remarkably, around 38% of all adRP cases analysed showed mutations affecting the splicing process, mainly due to mutations in genes coding for spliceosome factors (SNRNP200 and PRPF8) but also due to splice-site mutations in RHO. Twelve of the 14 mutations found had been reported previously and two were novel mutations found in PRPF8 in two unrelated patients. In conclusion, our results will lead to more accurate genetic counselling and will contribute to a better characterisation of the disease. In addition, they may have a therapeutic impact in the future given the large number of studies currently underway based on targeted RNA splicing for therapeutic purposes. Nature Publishing Group 2017-01-03 /pmc/articles/PMC5206707/ /pubmed/28045043 http://dx.doi.org/10.1038/srep39652 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Ezquerra-Inchausti, Maitane
Barandika, Olatz
Anasagasti, Ander
Irigoyen, Cristina
López de Munain, Adolfo
Ruiz-Ederra, Javier
High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa
title High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa
title_full High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa
title_fullStr High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa
title_full_unstemmed High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa
title_short High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa
title_sort high prevalence of mutations affecting the splicing process in a spanish cohort with autosomal dominant retinitis pigmentosa
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206707/
https://www.ncbi.nlm.nih.gov/pubmed/28045043
http://dx.doi.org/10.1038/srep39652
work_keys_str_mv AT ezquerrainchaustimaitane highprevalenceofmutationsaffectingthesplicingprocessinaspanishcohortwithautosomaldominantretinitispigmentosa
AT barandikaolatz highprevalenceofmutationsaffectingthesplicingprocessinaspanishcohortwithautosomaldominantretinitispigmentosa
AT anasagastiander highprevalenceofmutationsaffectingthesplicingprocessinaspanishcohortwithautosomaldominantretinitispigmentosa
AT irigoyencristina highprevalenceofmutationsaffectingthesplicingprocessinaspanishcohortwithautosomaldominantretinitispigmentosa
AT lopezdemunainadolfo highprevalenceofmutationsaffectingthesplicingprocessinaspanishcohortwithautosomaldominantretinitispigmentosa
AT ruizederrajavier highprevalenceofmutationsaffectingthesplicingprocessinaspanishcohortwithautosomaldominantretinitispigmentosa